Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation

被引：136
作者：
Thomas, T [1 ]
Nadackal, TG [1 ]
Thomas, K [1 ]
机构：
[1] Woodlands Med Ctr & Endron Therapeut, Oldsmar, FL 34677 USA
来源：
NEUROREPORT | 2001年 / 12卷 / 15期
关键词：
Alzheimer's disease; amyloid-beta; amyloid aggregation; amyloid plaque; aspirin; COX-2; inhibitors; inflammation; neurotoxicity; NSAIDs;
D O I：
10.1097/00001756-200110290-00024
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The neurotoxic and proinflammatory actions of the Alzheimer peptide amyloid-beta (A beta) are dependent on its aggregation and beta -sheet conformation. Chronic use of non-steroidal antiinflammatory drugs (NSAIDs) such as aspirin for arthritis decreases the risk of developing Alzheimer's disease (AD) by unknown mechanisms. We report that these drugs inhibit human A beta aggregation in vitro and reverse the beta -sheet conformation of preformed fibrils at clinically relevant doses. Aspirin prevented enhanced A beta aggregation by aluminum, an environmental risk factor for AD. This anti-aggregatory effect was restricted to NSAIDs and was not exhibited by other drugs used in AD therapy. NSAIDS may have a role in the prevention and treatment of AD, in addition to a number of age-related disorders such as arthritis, cardiovascular disease and cancer. NeuroReport 12:3263-3267 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：3263 / 3267
页数：5
相关论文
共 30 条
  • [1] [Anonymous], 1907, Centralblatt fur Nervenheilkunde Psychiatrie
  • [2] Impairment of the ubiquitin-proteasome system by protein aggregation
    Bence, NF
    Sampat, RM
    Kopito, RR
    [J]. SCIENCE, 2001, 292 (5521) : 1552 - 1555
  • [3] Secretases as targets for the treatment of Alzheimer's disease
    Citron, M
    [J]. MOLECULAR MEDICINE TODAY, 2000, 6 (10): : 392 - 397
  • [4] Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's Aβ peptide
    Cribbs, DH
    Azizeh, BY
    Cotman, CW
    LaFerla, FM
    [J]. BIOCHEMISTRY, 2000, 39 (20) : 5988 - 5994
  • [5] BLOOD CONCENTRATION OF NORADRENALINE IN DOG AFTER INTRAVENOUS ADMINISTRATION AND EFFECTS OF DESIPRAMINE
    EBLE, JN
    GOWDEY, CW
    VANE, JR
    [J]. NATURE, 1971, 231 (5299) : 181 - &
  • [6] FURST DE, 2000, BASIC CLIN PHARM, P596
  • [7] Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
    Janus, C
    Pearson, J
    McLaurin, J
    Mathews, PM
    Jiang, Y
    Schmidt, SD
    Chishti, MA
    Horne, P
    Heslin, D
    French, J
    Mount, HTJ
    Nixon, RA
    Mercken, M
    Bergeron, C
    Fraser, PE
    St George-Hyslop, P
    Westaway, D
    [J]. NATURE, 2000, 408 (6815) : 979 - 982
  • [8] Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes
    Kahn, SE
    Andrikopoulos, S
    Verchere, CB
    [J]. DIABETES, 1999, 48 (02) : 241 - 253
  • [9] The cyclooxygenase-2 inhibitors: Safety and effectiveness
    Kaplan-Machlis, B
    Klostermeyer, BS
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) : 979 - 988
  • [10] Aberrant protein deposition and neurological disease
    Kaytor, MD
    Warren, ST
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (53) : 37507 - 37510
123